Published in Int J Womens Health on May 31, 2017
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med (2012) 20.03
Preexposure prophylaxis for HIV infection among African women. N Engl J Med (2012) 15.28
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet (2015) 9.40
Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med (2015) 9.20
Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis (2010) 4.28
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med (2015) 4.26
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med (2016) 3.82
Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV. Am J Public Health (2000) 3.37
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS (2012) 2.19
Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. J Infect Dis (2009) 2.08
Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition - United States, 2015. MMWR Morb Mortal Wkly Rep (2015) 2.05
Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial. JAMA (2014) 1.73
Addressing poverty as risk for disease: recommendations from CDC's consultation on microenterprise as HIV prevention. Public Health Rep (2008) 1.41
Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. J Community Health (2004) 1.40
Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav (2012) 1.39
Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women. N Engl J Med (2016) 1.37
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine. J Infect Dis (2016) 1.26
Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine. Clin Infect Dis (1999) 1.22
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS (2016) 1.20
Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS (2014) 1.19
Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women. AIDS (2015) 1.10
A pill for HIV prevention: déjà vu all over again? Clin Infect Dis (2013) 1.08
The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access. AIDS Behav (2014) 1.07
Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav (2012) 1.03
Efficacy of a single-session HIV prevention intervention for black women: a group randomized controlled trial. AIDS Behav (2010) 0.99
Medical mistrust is related to lower longitudinal medication adherence among African-American males with HIV. J Health Psychol (2014) 0.96
Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDS (2014) 0.95
Facilitators of adherence to the study pill in the FEM-PrEP clinical trial. PLoS One (2015) 0.94
Alcohol Use Predicts Sexual Decision-Making: A Systematic Review and Meta-Analysis of the Experimental Literature. AIDS Behav (2016) 0.90
Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners. J Infect Dis (2015) 0.90
Healthcare Access and PrEP Continuation in San Francisco and Miami Following the U.S. PrEP Demo Project. J Acquir Immune Defic Syndr (2016) 0.89
Sex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture. PLoS One (2014) 0.88
Fear of violent consequences and condom use among women attending an STD clinic. Women Health (2013) 0.88
Racial differences and correlates of potential adoption of preexposure prophylaxis: results of a national survey. J Acquir Immune Defic Syndr (2013) 0.87
Gender Roles and Mental Health in Women With and at Risk for HIV. Psychol Women Q (2014) 0.86
United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey. Contraception (2016) 0.86
Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption. PLoS Med (2016) 0.85
Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis. AIDS Patient Care STDS (2014) 0.85
Depressive symptoms, HIV medication adherence, and HIV clinical outcomes in Tanzania: a prospective, observational study. PLoS One (2014) 0.84
Critical consciousness, racial and gender discrimination, and HIV disease markers in African American women with HIV. AIDS Behav (2014) 0.83
Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date. HIV AIDS (Auckl) (2016) 0.83
Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care (2016) 0.82
A Qualitative Study of Medical Mistrust, Perceived Discrimination, and Risk Behavior Disclosure to Clinicians by U.S. Male Sex Workers and Other Men Who Have Sex with Men: Implications for Biomedical HIV Prevention. J Urban Health (2015) 0.82
Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers. Am J Obstet Gynecol (2016) 0.82
Most Black women have a regular source of hair care--but not medical care. J Natl Med Assoc (2006) 0.81
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. Open Forum Infect Dis (2016) 0.81
Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis. J Acquir Immune Defic Syndr (2016) 0.80
Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials. J Acquir Immune Defic Syndr (2016) 0.80
The Potential of Pre-Exposure Prophylaxis for Women in Violent Relationships. AIDS Patient Care STDS (2016) 0.80
Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial. BMC Pharmacol Toxicol (2014) 0.79
Renal disease associated with antiretroviral therapy in the treatment of HIV. Nephron Clin Pract (2011) 0.79
Gender role behaviors of high affiliation and low self-silencing predict better adherence to antiretroviral therapy in women with HIV. AIDS Patient Care STDS (2014) 0.79
Factors Associated with Recent HIV Testing among Heterosexuals at High Risk for HIV Infection in New York City. Front Public Health (2016) 0.79
Community-based program to prevent HIV/STD infection among heterosexual black women. MMWR Surveill Summ (2014) 0.78
Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study. J Acquir Immune Defic Syndr (2016) 0.78
Young adult women and correlates of potential adoption of pre-exposure prophylaxis (PrEP): results of a national survey. Curr HIV Res (2013) 0.77
Injectable agents for pre-exposure prophylaxis: lessons learned from contraception to inform HIV prevention. Curr Opin HIV AIDS (2015) 0.77
Resilience Moderates the Association Between Childhood Sexual Abuse and Depressive Symptoms Among Women with and At-Risk for HIV. AIDS Behav (2015) 0.77
Importance of substance use and violence in psychosocial syndemics among women with and at-risk for HIV. AIDS Care (2016) 0.77
Economic Context and HIV Vulnerability in Adolescents and Young Adults Living in Urban Slums in Kenya: A Qualitative Analysis Based on Scarcity Theory. AIDS Behav (2017) 0.76
Sex Disparities in Adverse Childhood Experiences and HIV/STIs: Mediation of Psychopathology and Sexual Behaviors. AIDS Behav (2016) 0.76
Intimate partner violence is linked to less HIV testing uptake among high-risk, HIV-negative women in Atlanta. AIDS Care (2016) 0.75
Beyond the syndemic: condom negotiation and use among women experiencing partner violence. AIDS Care (2016) 0.75
Impact of food, housing, and transportation insecurity on ART adherence: a hierarchical resources approach. AIDS Care (2016) 0.75
The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study. AIDS Behav (2016) 0.75